Guardant Health, Inc.
GH
$98.71
-$0.21-0.21%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 14.27% | 14.06% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 14.27% | 14.06% | |||
| Cost of Revenue | 15.25% | 8.67% | |||
| Gross Profit | 13.74% | 17.19% | |||
| SG&A Expenses | 6.43% | 12.49% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.63% | 7.72% | |||
| Operating Income | 6.88% | 3.95% | |||
| Income Before Tax | 7.28% | -5.26% | |||
| Income Tax Expenses | 257.89% | -86.90% | |||
| Earnings from Continuing Operations | 7.18% | -4.98% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 7.18% | -4.98% | |||
| EBIT | 6.88% | 3.95% | |||
| EBITDA | 6.94% | 4.16% | |||
| EPS Basic | 7.70% | -4.78% | |||
| Normalized Basic EPS | 7.69% | -11.24% | |||
| EPS Diluted | 7.70% | -4.78% | |||
| Normalized Diluted EPS | 7.69% | -11.24% | |||
| Average Basic Shares Outstanding | 0.56% | 0.20% | |||
| Average Diluted Shares Outstanding | 0.56% | 0.20% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||